These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 1661671)

  • 1. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.
    Huibregtse JM; Scheffner M; Howley PM
    EMBO J; 1991 Dec; 10(13):4129-35. PubMed ID: 1661671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins.
    Scheffner M; Münger K; Huibregtse JM; Howley PM
    EMBO J; 1992 Jul; 11(7):2425-31. PubMed ID: 1321031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins.
    Scheffner M; Takahashi T; Huibregtse JM; Minna JD; Howley PM
    J Virol; 1992 Aug; 66(8):5100-5. PubMed ID: 1321290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53.
    Huibregtse JM; Scheffner M; Howley PM
    Mol Cell Biol; 1993 Feb; 13(2):775-84. PubMed ID: 8380895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.
    Scheffner M; Werness BA; Huibregtse JM; Levine AJ; Howley PM
    Cell; 1990 Dec; 63(6):1129-36. PubMed ID: 2175676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
    Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
    Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation.
    Crook T; Tidy JA; Vousden KH
    Cell; 1991 Nov; 67(3):547-56. PubMed ID: 1657399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical co-expression of human papillomavirus type 16/18 transforming (E6) oncoprotein and p53 tumour suppressor gene proteins in oesophageal cancer.
    Agarwal SK; Chatterji A; Bhambhani S; Sharma BK
    Indian J Exp Biol; 1998 Jun; 36(6):559-63. PubMed ID: 9731468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 in complex with DNA is resistant to ubiquitin-dependent proteolysis in the presence of HPV-16 E6.
    Molinari M; Milner J
    Oncogene; 1995 May; 10(9):1849-54. PubMed ID: 7753560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes.
    Hubbert NL; Sedman SA; Schiller JT
    J Virol; 1992 Oct; 66(10):6237-41. PubMed ID: 1326671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E6 variant proteins E6I-E6IV of human papillomavirus 16: expression in cell free systems and bacteria and study of their interaction with p53.
    Shally M; Alloul N; Jackman A; Muller M; Gissmann L; Sherman L
    Virus Res; 1996 Jun; 42(1-2):81-96. PubMed ID: 8806176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of p53 DNA binding by human papillomavirus E6 proteins.
    Lechner MS; Laimins LA
    J Virol; 1994 Jul; 68(7):4262-73. PubMed ID: 8207801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoexpression of mutant p53 and human papillomavirus related E6 oncoprotein in anal malignancies.
    Gupta S; Sharma BK
    Indian J Exp Biol; 1998 Sep; 36(9):875-8. PubMed ID: 9854426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest.
    Foster SA; Demers GW; Etscheid BG; Galloway DA
    J Virol; 1994 Sep; 68(9):5698-705. PubMed ID: 8057451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillomavirus E6 PDZ interactions can be replaced by repression of p53 to promote episomal human papillomavirus genome maintenance.
    Brimer N; Vande Pol SB
    J Virol; 2014 Mar; 88(5):3027-30. PubMed ID: 24352452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the interactions of human papillomavirus type 16 E6 with p53 and E6-associated protein in insect and human cells.
    Daniels PR; Sanders CM; Maitland NJ
    J Gen Virol; 1998 Mar; 79 ( Pt 3)():489-99. PubMed ID: 9519827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription.
    Lechner MS; Mack DH; Finicle AB; Crook T; Vousden KH; Laimins LA
    EMBO J; 1992 Aug; 11(8):3045-52. PubMed ID: 1379175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.
    Scheffner M; Huibregtse JM; Vierstra RD; Howley PM
    Cell; 1993 Nov; 75(3):495-505. PubMed ID: 8221889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
    Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
    Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines.
    Mantovani F; Banks L
    Oncogene; 1999 Jun; 18(22):3309-15. PubMed ID: 10362351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.